Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrative Metabolomic and Transcriptomic Analysis for the Study of Bladder Cancer

16 May 2019

Abstract excerpt

Metabolism reprogramming is considered a hallmark of cancer. The study of bladder cancer (BC) metabolism could be the key to developing new strategies for diagnosis and therapy. This work aimed to identify tissue and urinary metabolic signatures as biomarkers of BC and get further insight into BC tumor biology through the study of gene-metabolite networks and the integration of metabolomics and transcriptomics...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Cancer, Hypoxia, and Metabolism
Share to Metabolomics and Mass Spectrometry Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31100982
DOI: 10.3390/cancers11050686

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrative Metabolomic and Transcriptomic Analysis for the Study of Bladder CancerPMID 31100982Read ↗

Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder CancerSemantic proximity Read ↗

Integrated spatial transcriptome and metabolism study reveals metabolic heterogeneity in human bladder cancerSemantic proximity Read ↗

Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder CancerSemantic proximity Read ↗

Integrative Pathway Analysis of Metabolic Signature in Bladder Cancer: A Linkage to The Cancer Genome Atlas Project and Prediction of SurvivalSemantic proximity Read ↗

The Interplay Between Oxidative Phosphorylation and Glycolysis as a Potential Marker of Bladder Cancer Progression in Vitro and in VivoSemantic proximity Read ↗

Unmasking molecular profiles of bladder cancer.Semantic proximity Read ↗

Epigenetic dysregulation-induced metabolic reprogramming fuels tumor progression in bladder cancerSemantic proximity Read ↗

Metabolic‐associated signature and hub genes associated with immune microenvironment and prognosis in bladder cancerSemantic proximity Read ↗

Integrated multi-omics analysis reveals key genetic, metabolic, and microbial drivers in bladder cancer insights into molecular subtyping and therapeutic approaches: A tumor marker prognostic studySemantic proximity Read ↗

A novel molecular classification based on TP53 mutation to predict bladder cancer prognosis and immunotherapy efficacySemantic proximity Read ↗

Construction and validation of a prognostic model of metabolism-related genes driven by somatic mutation in bladder cancerSemantic proximity Read ↗

Identification and experimental validation of biomarkers associated with amino acid metabolism and ferroptosis in bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.